DK0473724T3 - Et humant cytokin, interleukin-9 - Google Patents

Et humant cytokin, interleukin-9

Info

Publication number
DK0473724T3
DK0473724T3 DK90909935.0T DK90909935T DK0473724T3 DK 0473724 T3 DK0473724 T3 DK 0473724T3 DK 90909935 T DK90909935 T DK 90909935T DK 0473724 T3 DK0473724 T3 DK 0473724T3
Authority
DK
Denmark
Prior art keywords
interleukin
protein
human cytokine
human
encode
Prior art date
Application number
DK90909935.0T
Other languages
English (en)
Inventor
Steven C Clark
Yu-Chung Yang
Agnes B Ciarletta
Susan T Ricciardi
Robert E Donahue
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of DK0473724T3 publication Critical patent/DK0473724T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5425—IL-9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90909935.0T 1989-05-23 1990-05-18 Et humant cytokin, interleukin-9 DK0473724T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35603389A 1989-05-23 1989-05-23
US07/515,308 US5580753A (en) 1989-05-23 1990-04-27 DNA encoding the human cytokine, interleukin-9

Publications (1)

Publication Number Publication Date
DK0473724T3 true DK0473724T3 (da) 1997-04-14

Family

ID=26999092

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909935.0T DK0473724T3 (da) 1989-05-23 1990-05-18 Et humant cytokin, interleukin-9

Country Status (10)

Country Link
US (2) US5580753A (da)
EP (1) EP0473724B1 (da)
JP (1) JP2914393B2 (da)
AT (1) ATE147436T1 (da)
AU (1) AU637620B2 (da)
CA (1) CA2056997C (da)
DE (1) DE69029657T2 (da)
DK (1) DK0473724T3 (da)
ES (1) ES2099096T3 (da)
WO (1) WO1990014432A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
US5925750A (en) * 1990-10-19 1999-07-20 Institute National De La Sante Et De La Recherche Medicale (Inserm) Nucleic acid encoding polypeptide of a growth factor receptor family
US5723315A (en) * 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5985602A (en) * 1996-08-14 1999-11-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5945302A (en) * 1996-04-05 1999-08-31 Genetics Institute, Inc. Polynucleotides encoding secreted proteins
US5708157A (en) * 1996-07-26 1998-01-13 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5728819A (en) * 1996-08-02 1998-03-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5965388A (en) * 1996-07-09 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5654173A (en) * 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5908839A (en) 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US6509313B1 (en) * 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
WO1998001469A2 (en) * 1996-06-19 1998-01-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2000514297A (ja) * 1996-07-09 2000-10-31 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
WO1998004695A1 (en) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998004696A1 (en) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2261581A1 (en) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998005781A1 (en) * 1996-08-02 1998-02-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2000516816A (ja) * 1996-08-23 2000-12-19 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
US5830454A (en) * 1996-08-30 1998-11-03 Ludwig Institute For Cancer Research Method for treating cell mediated autoimmune disorders using interleukin-9
JP2001504688A (ja) * 1996-10-04 2001-04-10 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
WO1998014575A1 (en) * 1996-10-04 1998-04-09 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them________________________________________________________________________________________________________________________________________________
WO1998014470A2 (en) * 1996-10-04 1998-04-09 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2269755A1 (en) * 1996-10-25 1998-04-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2002515753A (ja) * 1996-11-01 2002-05-28 ジェネティックス・インスティテュート・インコーポレイテッド 分泌蛋白およびそれらをコードしているポリヌクレオチド
CA2275535A1 (en) * 1996-11-06 1998-05-14 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2002514058A (ja) * 1996-11-15 2002-05-14 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
WO1998024904A2 (en) 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
CA2273845A1 (en) * 1996-12-06 1998-06-11 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998027997A1 (en) * 1996-12-20 1998-07-02 Magainin Pharmaceuticals Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
AU6022198A (en) * 1997-01-09 1998-08-03 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998030696A2 (en) * 1997-01-13 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2002512507A (ja) * 1997-01-21 2002-04-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
WO1998031799A2 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
AU5828398A (en) * 1997-01-24 1998-08-18 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US5965397A (en) * 1997-01-31 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2281059A1 (en) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP1352962A1 (en) * 1997-03-07 2003-10-15 Human Genome Sciences, Inc. 186 human secreted proteins
US7053190B2 (en) 1997-03-07 2006-05-30 Human Genome Sciences, Inc. Secreted protein HRGDF73
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
EP0972029A1 (en) 1997-03-07 2000-01-19 Human Genome Sciences, Inc. Human secreted proteins
US6878687B1 (en) 1997-03-07 2005-04-12 Human Genome Sciences, Inc. Protein HMAAD57
US6420526B1 (en) 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
US5976837A (en) * 1997-03-14 1999-11-02 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2001522239A (ja) * 1997-03-21 2001-11-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ８７個のヒト分泌タンパク質
JP2001518793A (ja) * 1997-04-10 2001-10-16 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）
EP0973898A2 (en) * 1997-04-10 2000-01-26 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
EP0973896A2 (en) * 1997-04-10 2000-01-26 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA2295474A1 (en) * 1997-07-08 1999-01-21 Human Genome Sciences, Inc. 123 human secreted proteins
JP2003525566A (ja) * 1997-11-07 2003-09-02 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド １２５個のヒト分泌タンパク質
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
AU7986300A (en) * 1999-09-27 2001-04-30 Human Genome Sciences, Inc. 43 human secreted proteins
EP1235907A4 (en) * 1999-11-12 2003-07-30 Human Genome Sciences Inc 6 HUMAN SECRETED PROTEINS
JP2003513658A (ja) * 1999-11-12 2003-04-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド １５個のヒト分泌タンパク質
ATE540695T1 (de) 2001-06-08 2012-01-15 Genaera Corp Verfahren zur modulation von il-13

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9

Also Published As

Publication number Publication date
JPH04506006A (ja) 1992-10-22
WO1990014432A1 (en) 1990-11-29
DE69029657D1 (de) 1997-02-20
US5734037A (en) 1998-03-31
AU5928990A (en) 1990-12-18
ATE147436T1 (de) 1997-01-15
EP0473724B1 (en) 1997-01-08
JP2914393B2 (ja) 1999-06-28
ES2099096T3 (es) 1997-05-16
CA2056997A1 (en) 1990-11-24
AU637620B2 (en) 1993-06-03
EP0473724A1 (en) 1992-03-11
US5580753A (en) 1996-12-03
DE69029657T2 (de) 1997-08-07
CA2056997C (en) 2001-01-30

Similar Documents

Publication Publication Date Title
DK0473724T3 (da) Et humant cytokin, interleukin-9
ATE114169T1 (de) Morphogenetisches knochenprotein.
ATE326476T1 (de) Verfahren zur herstellung von phosphorothioat- oligomeren
ATE169335T1 (de) Zusammensetzungen und verfahren zur anregung des wachstums und der differenzierung von megakaryozyten
ATE243743T1 (de) Dna, die für pflanzliche thioesterasen kodiert
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
RU95115239A (ru) Аналог эритропоэтина
DE3882242D1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
SE8801701D0 (sv) Production technology based on enzymic method
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE88500T1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
ATE64154T1 (de) Verfahren zur herstellung von l-carnitin auf mikrobiologischem weg.
FI103577B1 (fi) Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
DE68919282D1 (de) Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
ATE353368T1 (de) Verfahren zur herstellung verzweigtkettiger fettsäuren mittels genetisch modifizierter pflanzen
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
RU94043698A (ru) СПОСОБ ПОЛУЧЕНИЯ ФЕРМЕНТА ДЕСТАБИЛАЗЫ, ОБЛАДАЮЩЕГО ФИБРИНОЛИТИЧЕСКОЙ, ТРОМБОЛИТИЧЕСКОЙ, ЭНДО- И ЭКЗО- Е( -glu)-Lys-ИЗОПЕПТИДАЗНОЙ И АМИДОЛИТИЧЕСКОЙ АКТИВНОСТЬЮ
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
DE3880072D1 (de) N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins.